Application 021908

Type
NDA
Sponsor
SUCAMPO PHARMA LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AMITIZALUBIPROSTONECAPSULE;ORAL24MCGYesYes
002AMITIZALUBIPROSTONECAPSULE;ORAL8MCGYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0254-3028LubiprostoneLubiprostonePar Pharmaceutical Inc.NDA AUTHORIZED GENERICCurrent
0254-3028LubiprostoneLubiprostonePar Pharmaceutical Inc.NDA AUTHORIZED GENERICCurrent
0254-3028LubiprostoneLubiprostonePar Pharmaceutical Inc.NDA AUTHORIZED GENERICCurrent
0254-3029LubiprostoneLubiprostonePar Pharmaceutical Inc.NDA AUTHORIZED GENERICCurrent
0254-3029LubiprostoneLubiprostonePar Pharmaceutical Inc.NDA AUTHORIZED GENERICCurrent
0254-3029LubiprostoneLubiprostonePar Pharmaceutical Inc.NDA AUTHORIZED GENERICCurrent
35356-500AmitizalubiprostoneLake Erie Medical DBA Quality Care Products LLCNDACurrent
35356-500AmitizalubiprostoneLake Erie Medical DBA Quality Care Products LLCNDACurrent
43598-163LubiprostoneLubiprostoneDr. Reddy's Laboratories Inc.NDA AUTHORIZED GENERICCurrent
43598-168LubiprostoneLubiprostoneDr. Reddy's Laboratories Inc.NDA AUTHORIZED GENERICCurrent
55700-963LubiprostoneLubiprostoneQuality Care Products, LLCNDA AUTHORIZED GENERICCurrent
55700-963LubiprostoneLubiprostoneQuality Care Products, LLCNDA AUTHORIZED GENERICCurrent
63304-351LubiprostonelubiprostoneSun Pharmaceutical Industries, Inc.NDA AUTHORIZED GENERICCurrent
63304-352LubiprostonelubiprostoneSun Pharmaceutical Industries, Inc.NDA AUTHORIZED GENERICCurrent
63629-6398AmitizalubiprostoneBryant Ranch PrepackNDACurrent
63629-6398AmitizalubiprostoneBryant Ranch PrepackNDACurrent
64764-080AmitizalubiprostoneTakeda Pharmaceuticals America, Inc.NDACurrent
64764-080AmitizalubiprostoneTakeda Pharmaceuticals America, Inc.NDACurrent
64764-080AmitizalubiprostoneTakeda Pharmaceuticals America, Inc.NDACurrent
64764-080AmitizalubiprostoneTakeda Pharmaceuticals America, Inc.NDACurrent
64764-080AmitizalubiprostoneTakeda Pharmaceuticals America, Inc.NDACurrent
64764-080AmitizalubiprostoneTakeda Pharmaceuticals America, Inc.NDACurrent
64764-240AmitizalubiprostoneTakeda Pharmaceuticals America, Inc.NDACurrent
64764-240AmitizalubiprostoneTakeda Pharmaceuticals America, Inc.NDACurrent
64764-240AmitizalubiprostoneTakeda Pharmaceuticals America, Inc.NDACurrent
64764-240AmitizalubiprostoneTakeda Pharmaceuticals America, Inc.NDACurrent
64764-240AmitizalubiprostoneTakeda Pharmaceuticals America, Inc.NDACurrent
64764-240AmitizalubiprostoneTakeda Pharmaceuticals America, Inc.NDACurrent
68151-5003AmitizalubiprostoneCarilion Materials ManagementNDACurrent
69339-162LUBIPROSTONELUBIPROSTONEDASH Pharmaceuticals LLCNDACurrent
69339-163LUBIPROSTONELUBIPROSTONEDASH Pharmaceuticals LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
65500SUPPL2020-12-04
65442SUPPL2020-12-01
53906SUPPL2018-05-01
53862SUPPL2018-04-27
49216SUPPL2017-08-02
49204SUPPL2017-08-02
45750SUPPL2016-11-01
45543SUPPL2016-10-14
42346SUPPL2015-08-21
42345SUPPL2013-08-06
6434SUPPL2013-04-24
16558SUPPL2013-04-23
28826SUPPL2012-11-28
16557SUPPL2012-11-26
21867SUPPL2012-11-09
16556SUPPL2011-03-04
28825SUPPL2011-03-01
42344SUPPL2010-05-03
24226SUPPL2008-07-17
6433SUPPL2008-05-05
16555SUPPL2008-05-02
37864SUPPL2007-05-29
28824SUPPL2007-05-29
21866ORIG2006-03-24
37863ORIG2006-02-02
28823ORIG2006-02-02
63133SUPPL1900-01-01
63132SUPPL1900-01-01
63131SUPPL1900-01-01